03.07.2025 | Exzellenzcluster „Controlling Microbes to Fight Infections“ (CMFI), Interfakultäres Institut für Mikrobiologie und Infektionsmedizin
| Datum : | |
|---|---|
| Veranstaltungsort : | |
| Referent/in : |
Christoph Ernst, Uniklinik Köln, Andreas Peschel, CMFI |
| Weiterführende Informationen : | https://www.cmfi.uni-tuebingen.de/aktuelles/veranstaltungen/ernst |
Within-patient selected adaptive mutations have the potential to reveal important insights into bacterial pathogenesis and antibiotic treatment failure. We previously discovered global adaptive evolution of virulence and persistence in multidrug-resistant Klebsiella pneumoniae infections. A detailed mechanistic investigation of adaptive mutations revealed an intrinsic ability of Klebsiella pneumoniae to persist in LAMP1 positive compartments in bladder epithelial cells. Importantly, intracellular infection led to a magnitude increase in antibiotic persistence resulting in an untreatable infection. Targeting these intracellular persisters in a chemical screen led to the discovery of a compound with remarkable broad-spectrum intracellular antimicrobial activity. Ongoing mode of action studies point to a novel antimicrobial strategy involving the induction of a new pathway of cell autonomous immunity. A better understanding of selective pressures in host pathogen systems may not only lead to a better understanding of bacterial pathogenicity and treatment failure but may also inform new approaches to treat bacterial infections.
Öffentliche Veranstaltung. Keine Anmeldung erforderlich.